Polypharmacotherapy – When it is Treatment of the First orSecond Choice? Part II.

Czech version

Authors: E. Češková; T. Kašpárek
Authors‘ workplace: Psychiatrická klinika LF MU a FN, Brno, přednosta prof. MUDr. E. Češková, CSc.
Published in: Čes. a slov. Psychiat., , 2003, No. 4, pp. 189-193.
Category:

Overview

Polypharmacotherapy is very frequently used in the bipolar and psychotic depression and in thepharmacoresistant schizophrenia. For all these indications only a few controlled double-blindstudies are available. Emergence of atypical antipsychotics represents another aspect of theproblem. In the bipolar depression, mood stabilizers or their combinations are adequate for milddepression only. In more severe depression the transitory use of combinations with antidepressantsis recommended; in resistant and psychotic depression combinations with atypical antipsychoticscan be temporally used. In pharmacoresistant schizophrenia the augmentation strategies(lithium, anticonvulsants) are not applied very often, the combinations of several antipsychoticswith different and mutually complementary pharmacological profile have been employed morefrequently. Such combinations should be used after a trial of monotherapy with clozapine.

Key words:
polypharmacotherapy, bipolar depression, psychotic depression, pharmacoresistantschizophrenia, combination, augmentation.

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Addictology Paediatric psychiatry Psychiatry

Polymorphism of the IL-6 Geneis in the Relationship with the Disposition to the Alcohol Dependence

Present Trends in the Psychotherapeutic Research: II. Research of thePsychotherapeutic Process

Cannabinoids, Psychoses and Schizophrenia

Do we Know how to Diagnose and Treat Bipolar Disorder?

Article was published in

Czech and Slovak Psychiatry

2003 Issue 4